Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.3250
+0.0100 (3.17%)
At close: Sep 17, 2026
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 43.19 million as of September 17, 2026. Its market cap has decreased by -17.01% in one year.
Market Cap
43.19M
Enterprise Value
36.97M
Revenue
1.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.33
ChartMarket Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 43.19M, an increase of 68.06%. That is a compound annual growth rate of 18.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 43.19M | -47.84% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saluda Medical | 105.85M |
| Lumos Diagnostics Holdings | 94.48M |
| SomnoMed | 70.33M |
| Cyclopharm | 67.90M |
| Epiminder | 65.00M |
| Compumedics | 54.93M |
| Nova Eye Medical | 38.46M |
| HeraMED | 38.24M |